UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039580
Receipt number R000044283
Scientific Title The efficacy of HCV eradication with direct-acting antivirals on patients with cirrhosis
Date of disclosure of the study information 2020/02/24
Last modified on 2020/02/24 10:20:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The efficacy of HCV eradication with direct-acting antivirals on patients with cirrhosis

Acronym

The efficacy of HCV clearance

Scientific Title

The efficacy of HCV eradication with direct-acting antivirals on patients with cirrhosis

Scientific Title:Acronym

The efficacy of HCV clearance

Region

Japan


Condition

Condition

HCV-related cirrhosis

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the effect of HCV eradication with direct-acting antivirals on patients with cirrhosis

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Portal hemodynamic change

Key secondary outcomes

Change of liver function/ fibrosis/inflammation/protein expression/gut microbiome


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

HCV realted cirrhosis

Key exclusion criteria

viable HCC

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Naoya
Middle name
Last name Kato

Organization

Chiba University Graduate School of Medicine

Division name

Deartment of Gastroenterology

Zip code

260-8670

Address

1-8-1, Inohana, Chuo-ku, Chiba, Japan

TEL

0432262083

Email

takakon@chiba-u.jp


Public contact

Name of contact person

1st name Takayuki
Middle name
Last name Kondo

Organization

Chiba University Graduate School of Medicine

Division name

Department of Gastroenterology

Zip code

260-8670

Address

1-8-1, Inohana, Chuo-ku, Chiba, Japan

TEL

0432262083

Homepage URL


Email

takakon@chiba-u.jp


Sponsor or person

Institute

Chiba University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

N/A

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Chiba Univesity Graduate School of Medicine, IRB

Address

1-8-1, Inohana, Chuo-ku, Chiba, Japan

Tel

0432227171

Email

igaku-rinri@office.chiba-u.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 02 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2019 Year 06 Month 01 Day

Date of IRB

2019 Year 06 Month 27 Day

Anticipated trial start date

2019 Year 10 Month 01 Day

Last follow-up date

2024 Year 10 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

N/A


Management information

Registered date

2020 Year 02 Month 24 Day

Last modified on

2020 Year 02 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044283


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name